Tag: apealea

January 15, 2019

European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea

Oasmia Pharmaceutical AB (NASDAQ:OASM) AB today announce that the European Medicines Agency (EMA) has validated a type II variation application...
November 29, 2018

Oasmia Pharmaceutical announces new agreement with Baxter Oncology

Oasmia Pharmaceutical (Nasdaq:OASM) today announce that the company has signed a new five-year contract with Baxter BioPharma Solutions for global...
November 22, 2018

Oasmia Pharmaceutical Receives EU Approval for Apealea

The approval will be valid in all 28 countries of the European Union, and in the European Economic Area of...
November 22, 2018

Oasmia Pharmaceutical Receives Approval from European Commission for Apealea

Oasmia Pharmaceutical (NASDAQ:OASM) today announce that the European Commission has granted an approval of Apealea for treatment of adult patients...